Lincoln Pharmaceuticals consolidated net profit rises 30.89% in the June 2026 quarter
(13 Aug 2026)
Back
Net profit of Lincoln Pharmaceuticals rose 30.89% to Rs 36.23 crore in the quarter ended June 2026 as against Rs 27.68 crore during the previous quarter ended June 2025. Sales rose 15.06% to Rs 177.28 crore in the quarter ended June 2026 as against Rs 154.07 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | | Jun. 2026 | Jun. 2025 | % Var. |
| Sales | 177.28 | 154.07 | 15 |
| OPM % | 15.48 | 15.45 | - |
| PBDT | 51.44 | 38.87 | 32 |
| PBT | 47.55 | 35.39 | 34 |
| NP | 36.23 | 27.68 | 31 |
|